We use cookies for a better user experience. Read our Privacy Policy
I Agree
Telemedicine Market
Analysts’ Viewpoint on Market Scenario
The COVID-19 pandemic has driven the global market in the last couple of years. Usage of telemedicine increased during the pandemic. Increase in government spending and reimbursement policies; rise in the demand for personal healthcare; and surge in technically aware & literate population have shifted the public preference from traditional medicine to telemedicine. Surge in private telemedicine solutions and favorable reimbursement scenario globally are augmenting the market.
Organizations are entering into partnerships to expand telemedicine solutions, which is expected to propel the market during the forecast period. Furthermore, increase in usage of emergency telemedicine services, online telemedicine services, and various types of telemedicine solutions and telemedicine technology are expected to drive the global market during the forecast period.
Telemedicine, or telehealth, is the delivery of healthcare services in remote areas using technology. The three primary types of telemedicine are interactive medicine, store & forward, and remote patient monitoring. Interactive medicine enables physicians and patients to communicate in real-time. Store & forward permits providers to share patient’s information with a practitioner in the different location. Remote patient monitoring enables caregivers to monitor patients who reside at home by using mobile medical devices in order to collect data such as blood sugar or blood pressure.
Presently, a large number of people have access to basic telemedicine devices such as mobile phones and computers. Improvement in accessibility has enabled individuals in rural and urban areas to connect with physicians conveniently. Home-use medical devices make it possible for caregivers to monitor everything from vitals to glucose levels. Physicians can even gather essential medical information and make a diagnosis without patients stepping foot in a doctor’s office.
According to WHO, telemedicine means ‘healing from distance’. It means the usage of telecommunication and information technologies to provide remote clinical services to patients. Mostly, physicians use telemedicine for the transmission of digital imaging, video consultations, digital diagnostics, and remote medical diagnosis.
Request a sample to get extensive insights into the Telemedicine Market
According to statistics, in 2021, the global population accessed Internet every day; around 4.9 billion people are Internet users. Digital population is increasing in several parts of the world; however, internet access and availability could differ significantly depending on the region. According to the National Health Interview Survey, 74% of the population of the U.S. accesses Internet every day. Of this, 64% have used the Internet to search for medical or health related information. Furthermore, 49% of these tech savvy individuals have used the Internet to search for a specific medical condition or issue. This indicates increased preference for Internet-based healthcare services. Rise in services and availability of e-healthcare is projected to drive the telemedicine and telehealth market during the forecast period.
Governments across the world have increased spending on healthcare and related services due to growing health concerns and rise in non-infectious diseases. According to the American Medical Association, health care expenditure in the U.S. increased by 9.7% in 2020 to US$ 4.1 Trn, or about US$ 12,530 per capita. This growth rate is significantly higher than in 2019. This is attributed to increase in government spending to manage the COVID-19 pandemic. It includes expenditure to disseminate vaccines and public health information, and for federal relief programs for health care organizations and providers. Health care spending in the country stood at 19.7% of the GDP in 2020, as against 17.6% in 2019.
According to the Institute for Fiscal Studies 2022, the U.K. Government spends nearly US$ 1001.34 Bn, or around US$ 14,851.32 per person, on healthcare. In March 2022, the Government of Australia announced a US$ 2.4 Bn health package to protect citizens with chronic conditions. This included assistance for health care practitioners to provide telehealth services, such as video conferencing software.
Request a custom report on Telemedicine Market
In terms of component type, the services segment is projected to account for major share of the global market by 2031. The services segment is anticipated to witness strong growth due to provision of cost-effective methods to consult doctors/physicians. Moreover, rise in demand for different telemedicine services, such as teleradiology, teledermatology, and telepsychiatry, is expected to propel the segment during the forecast period.
Based on specialty type, the telemedicine market has been segregated into dermatology, gynecology, neurology, cardiology, orthopedics, emergency care, internal medicine, and others. The dermatology segment accounted for the largest share of the global market in 2021. This is ascribed to increase in patient preference for tele-consultation for dermatological conditions.
In terms of service type, the global market has been divided into tele-consultation, tele-monitoring, tele-education, tele-training, tele-care, tele-surgery, and others. The tele-consultation segment dominated the global market in 2021. The segment is projected to grow at a high CAGR during the forecast period. This is ascribed to adoption of technologically-advanced products, increase in the number of people using smartphones and Internet services, and rise in usage of phones for consulting with doctors/physicians.
North America accounted for major share of the global market in 2021. The market in the region is likely to grow at a high CAGR from 2022 to 2031. Increase in the number of installations of telemedicine solutions in various clinics & hospitals and the presence of large number of the suppliers & service providers are expected to drive the market in the region. According to American Well’s Telehealth Index: 2019 Physician Survey, 340,000 to 590,000 physicians in the U.S. are estimated to use telehealth technology by 2022.
As per global telemedicine market analysis, Asia Pacific held the second-largest share of the global market in 2021. The market in the region is likely to grow at a rapid pace from 2022 to 2031. The number of initiatives taken by government organizations to endorse telemedicine has increased in the last few years. Surge in the geriatric population and presence of large pool of patients suffering from various diseases in countries, such as China and India, are propelling the market in Asia Pacific. Furthermore, the region is positioning itself as one of the best medical tourism regions for various types of treatments and surgeries, with cost-effective solutions. Therefore, patients from across the world are attracted to the region. Low labor cost, presence of several domestic manufacturers, and low production cost drive the demand for telemedicine installations in Asia Pacific.
The global telemedicine industry is fragmented, with the presence of a large number of local as well as international players. Expansion of product portfolio and mergers & acquisitions are prominent strategies adopted by key players. Leading players in the global market are Agfa-Gevaert Group, Allscripts Healthcare, LLC and/or its affiliates, AMD Global Telemedicine, CISCO Systems Inc., F. Hoffmann-La Roche Ltd., Honeywell HomMed LLC, InTouch Technologies, Inc., BioTelemetry, Inc., Medtronic, OBS Medical Ltd., Siemens Healthcare Private Limited, and McKesson Corporation.
Each of these players has been profiled in the telemedicine market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 144.2 Bn |
|
Market Forecast Value in 2031 |
More than US$ 526.7 Bn |
|
Growth Rate (CAGR) |
13.4% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
The global market was valued at US$ 144.2 Bn in 2021
The global market is projected to reach more than US$ 526.7 Bn by 2031
The global market advanced at a CAGR of 58.2% from 2017 to 2021
The global market is anticipated to advance at a CAGR of 13.4% from 2022 to 2031
Surge in usage of digital technologies for diagnosis & treatment of skin diseases and rise in applications of telemedicine technologies and services in numerous specialty fields such as dermatology, gynecology, neurology, and cardiology
North America is expected to account for the largest share of the global market during the forecast period.
Agfa-Gevaert Group, Allscripts Healthcare, LLC and/or its affiliates, AMD Global Telemedicine, CISCO Systems, Inc., F. Hoffmann-La Roche Ltd., Honeywell HomMed LLC, InTouch Technologies, Inc., BioTelemetry, Inc., Medtronic, OBS Medical Ltd., Siemens Healthcare Private Limited, and McKesson Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Telemedicine Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Telemedicine Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Reimbursement Scenario by Region/globally
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short-/Mid-/Long-term impact)
6. Global Telemedicine Market Analysis and Forecast, by Component Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Component Type, 2017–2031
6.3.1. Hardware
6.3.2. Software
6.3.3. Service Type
6.4. Market Attractiveness Analysis, by Component Type
7. Global Telemedicine Market Analysis and Forecast, by Specialty Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Specialty Type, 2017–2031
7.3.1. Dermatology
7.3.2. Gynecology
7.3.3. Neurology
7.3.4. Cardiology
7.3.5. Orthopedics
7.3.6. Emergency Care
7.3.7. Internal Medicine
7.3.8. Others
7.4. Market Attractiveness Analysis, by Specialty Type
8. Global Telemedicine Market Analysis and Forecast, by Service Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Service Type, 2017–2031
8.3.1. Tele-consultation
8.3.2. Tele-monitoring
8.3.3. Tele-education
8.3.4. Tele-training
8.3.5. Tele-care
8.3.6. Tele-surgery
8.3.7. Others
8.4. Market Attractiveness Analysis, by Service Type
9. Global Telemedicine Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Telemedicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Component Type, 2017–2031
10.2.1. Hardware
10.2.2. Software
10.2.3. Service Type
10.3. Market Value Forecast, by Specialty Type, 2017–2031
10.3.1. Dermatology
10.3.2. Gynecology
10.3.3. Neurology
10.3.4. Cardiology
10.3.5. Orthopedics
10.3.6. Emergency Care
10.3.7. Internal Medicine
10.3.8. Others
10.4. Market Value Forecast, by Service Type, 2017–2031
10.4.1. Tele-consultation
10.4.2. Tele-monitoring
10.4.3. Tele-education
10.4.4. Tele-training
10.4.5. Tele-care
10.4.6. Tele-surgery
10.4.7. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Component Type
10.6.2. By Specialty Type
10.6.3. By Service Type
10.6.4. By Country
11. Europe Telemedicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Component Type, 2017–2031
11.2.1. Hardware
11.2.2. Software
11.2.3. Service Type
11.3. Market Value Forecast, by Specialty Type, 2017–2031
11.3.1. Dermatology
11.3.2. Gynecology
11.3.3. Neurology
11.3.4. Cardiology
11.3.5. Orthopedics
11.3.6. Emergency Care
11.3.7. Internal Medicine
11.3.8. Others
11.4. Market Value Forecast, by Service Type, 2017–2031
11.4.1. Tele-consultation
11.4.2. Tele-monitoring
11.4.3. Tele-education
11.4.4. Tele-training
11.4.5. Tele-care
11.4.6. Tele-surgery
11.4.7. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Component Type
11.6.2. By Specialty Type
11.6.3. By Service Type
11.6.4. By Country/Sub-region
12. Asia Pacific Telemedicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Component Type, 2017–2031
12.2.1. Hardware
12.2.2. Software
12.2.3. Service Type
12.3. Market Value Forecast, by Specialty Type, 2017–2031
12.3.1. Dermatology
12.3.2. Gynecology
12.3.3. Neurology
12.3.4. Cardiology
12.3.5. Orthopedics
12.3.6. Emergency Care
12.3.7. Internal Medicine
12.3.8. Others
12.4. Market Value Forecast, by Service Type, 2017–2031
12.4.1. Tele-consultation
12.4.2. Tele-monitoring
12.4.3. Tele-education
12.4.4. Tele-training
12.4.5. Tele-care
12.4.6. Tele-surgery
12.4.7. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Component Type
12.6.2. By Specialty Type
12.6.3. By Service Type
12.6.4. By Country/Sub-region
13. Latin America Telemedicine Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Component Type, 2017–2031
13.2.1. Hardware
13.2.2. Software
13.2.3. Service Type
13.3. Market Value Forecast, by Specialty Type, 2017–2031
13.3.1. Dermatology
13.3.2. Gynecology
13.3.3. Neurology
13.3.4. Cardiology
13.3.5. Orthopedics
13.3.6. Emergency Care
13.3.7. Internal Medicine
13.3.8. Others
13.4. Market Value Forecast, by Service Type, 2017–2031
13.4.1. Tele-consultation
13.4.2. Tele-monitoring
13.4.3. Tele-education
13.4.4. Tele-training
13.4.5. Tele-care
13.4.6. Tele-surgery
13.4.7. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Component Type
13.6.2. By Specialty Type
13.6.3. By Service Type
13.6.4. By Country/Sub-region
14. Middle East & Africa Telemedicine Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Component Type, 2017–2031
14.2.1. Hardware
14.2.2. Software
14.2.3. Service Type
14.3. Market Value Forecast, by Specialty Type, 2017–2031
14.3.1. Dermatology
14.3.2. Gynecology
14.3.3. Neurology
14.3.4. Cardiology
14.3.5. Orthopedics
14.3.6. Emergency Care
14.3.7. Internal Medicine
14.3.8. Others
14.4. Market Value Forecast, by Service Type, 2017–2031
14.4.1. Tele-consultation
14.4.2. Tele-monitoring
14.4.3. Tele-education
14.4.4. Tele-training
14.4.5. Tele-care
14.4.6. Tele-surgery
14.4.7. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Component Type
14.6.2. By Specialty Type
14.6.3. By Service Type
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Agfa-Gevaert Group
15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
15.2.1.2. Financials
15.2.1.3. Recent Developments
15.2.1.4. Strategy
15.2.2. AMD Global Telemedicine
15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
15.2.2.2. Financials
15.2.2.3. Recent Developments
15.2.2.4. Strategy
15.2.3. CISCO Systems, Inc.
15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
15.2.3.2. Financials
15.2.3.3. Recent Developments
15.2.3.4. Strategy
15.2.4. F. Hoffmann-La Roche Ltd.
15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
15.2.4.2. Financials
15.2.4.3. Recent Developments
15.2.4.4. Strategy
15.2.5. Honeywell HomMed LLC
15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
15.2.5.2. Financials
15.2.5.3. Recent Developments
15.2.5.4. Strategy
15.2.6. InTouch Technologies, Inc.
15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
15.2.6.2. Financials
15.2.6.3. Recent Developments
15.2.6.4. Strategy
15.2.7. BioTelemetry, Inc.
15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
15.2.7.2. Financials
15.2.7.3. Recent Developments
15.2.7.4. Strategy
15.2.8. Medtronic
15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
15.2.8.2. Financials
15.2.8.3. Recent Developments
15.2.8.4. Strategy
15.2.9. OBS Medical Ltd.
15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
15.2.9.2. Financials
15.2.9.3. Recent Developments
15.2.9.4. Strategy
15.2.10. Siemens Healthcare Private Limited
15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
15.2.10.2. Financials
15.2.10.3. Recent Developments
15.2.10.4. Strategy
15.2.11. McKesson Corporation
15.2.11.1. Overview (HQ, Employee Strength, Business Segments)
15.2.11.2. Financials
15.2.11.3. Recent Developments
15.2.11.4. Strategy
List of Tables
Table 01: Global Telemedicine Market Value (US$ Mn) Forecast, by Component Type, 2017‒2031
Table 02: Global Telemedicine Market Value (US$ Mn) Forecast, by Specialty Type, 2017–2031
Table 03: Global Telemedicine Market Value (US$ Mn) Forecast, by Service Type, 2017–2031
Table 04: Global Telemedicine Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Telemedicine Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Telemedicine Market Value (US$ Mn) Forecast, by Component Type, 2017‒2031
Table 07: North America Telemedicine Market Value (US$ Mn) Forecast, by Specialty Type, 2017–2031
Table 08: North America Telemedicine Market Value (US$ Mn) Forecast, by Service Type, 2017–2031
Table 09: Europe Telemedicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Telemedicine Market Value (US$ Mn) Forecast, by Component Type, 2017‒2031
Table 11: Europe Telemedicine Market Value (US$ Mn) Forecast, by Specialty Type, 2017–2031
Table 12: Europe Telemedicine Market Value (US$ Mn) Forecast, by Service Type, 2017–2031
Table 13: Asia Pacific Telemedicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Telemedicine Market Value (US$ Mn) Forecast, by Component Type, 2017‒2031
Table 15: Asia Pacific Telemedicine Market Value (US$ Mn) Forecast, by Specialty Type, 2017–2031
Table 16: Asia Pacific Telemedicine Market Value (US$ Mn) Forecast, by Service Type, 2017–2031
Table 17: Latin America Telemedicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Telemedicine Market Value (US$ Mn) Forecast, by Component Type, 2017‒2031
Table 19: Latin America Telemedicine Market Value (US$ Mn) Forecast, by Specialty Type, 2017–2031
Table 20: Latin America Telemedicine Market Value (US$ Mn) Forecast, by Service Type, 2017–2031
Table 21: Middle East & Africa Telemedicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Telemedicine Market Value (US$ Mn) Forecast, by Component Type, 2017‒2031
Table 23: Middle East & Africa Telemedicine Market Value (US$ Mn) Forecast, by Specialty Type, 2017–2031
Table 24: Middle East & Africa Telemedicine Market Value (US$ Mn) Forecast, by Service Type, 2017–2031
Table 25: Middle East & Africa Telemedicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Telemedicine Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Telemedicine Market Value Share, by Component Type, 2021
Figure 03: Telemedicine Market Value Share, by Specialty Type, 2021
Figure 04: Telemedicine Market Value Share, by Service Type, 2021
Figure 05: Global Telemedicine Market Value Share Analysis, by Component Type, 2021 and 2031
Figure 06: Global Telemedicine Market Attractiveness Analysis, by Component Type, 2022–2031
Figure 07: Global Telemedicine Market Value (US$ Mn), by Hardware, 2017‒2031
Figure 08: Global Telemedicine Market Value (US$ Mn), by Software, 2017‒2031
Figure 09: Global Telemedicine Market Value (US$ Mn), by Service Type, 2017‒2031
Figure 10: Global Telemedicine Market Value Share Analysis, by Specialty Type, 2021 and 2031
Figure 11: Global Telemedicine Market Attractiveness Analysis, by Specialty Type, 2022–2031
Figure 12: Global Telemedicine Market Value (US$ Mn), by Dermatology, 2017–2031
Figure 13: Global Telemedicine Market Value (US$ Mn), by Gynecology, 2017–2031
Figure 14: Global Telemedicine Market Value (US$ Mn), by Neurology, 2017–2031
Figure 15: Global Telemedicine Market Value (US$ Mn), by Cardiology, 2017–2031
Figure 16: Global Telemedicine Market Value (US$ Mn), by Orthopedics, 2017–2031
Figure 17: Global Telemedicine Market Value (US$ Mn), by Emergency Medicine, 2017–2031
Figure 18: Global Telemedicine Market Value (US$ Mn), by Internal Medicine, 2017–2031
Figure 19: Global Telemedicine Market Value (US$ Mn), by Others, 2017–2031
Figure 20: Global Telemedicine Market Value Share Analysis, by Service Type, 2021 and 2031
Figure 21: Global Telemedicine Market Attractiveness Analysis, by Service Type, 2022–2031
Figure 22: Global Telemedicine Market Value (US$ Mn), by Tele-consultation, 2017–2031
Figure 23: Global Telemedicine Market Value (US$ Mn), by Tele-monitoring, 2017–2031
Figure 24: Global Telemedicine Market Value (US$ Mn), by Tele-education, 2017–2031
Figure 25: Global Telemedicine Market Value (US$ Mn), by Tele-training, 2017–2031
Figure 26: Global Telemedicine Market Value (US$ Mn), by Tele-care, 2017–2031
Figure 27: Global Telemedicine Market Value (US$ Mn), by Tele-surgery, 2017–2031
Figure 28: Global Telemedicine Market Value (US$ Mn), by Others, 2017–2031
Figure 29: Global Telemedicine Market Value Share Analysis, by Region, 2021 and 2031
Figure 30: Global Telemedicine Market Attractiveness Analysis, by Region, 2022–2031
Figure 31: North America Telemedicine Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: North America Telemedicine Market Value Share Analysis, by Country, 2021 and 2031
Figure 33: North America Telemedicine Market Attractiveness Analysis, by Country, 2022–2031
Figure 34: North America Telemedicine Market Value Share Analysis, by Component Type , 2021 and 2031
Figure 35: North America Telemedicine Market Attractiveness Analysis, by Component Type, 2022–2031
Figure 36: North America Telemedicine Market Value Share Analysis, by Specialty Type, 2021 and 2031
Figure 37: North America Telemedicine Market Attractiveness Analysis, by Specialty Type, 2022–2031
Figure 38: North America Telemedicine Market Value Share Analysis, by Service Type, 2021 and 2031
Figure 39: North America Telemedicine Market Attractiveness Analysis, by Service Type, 2022–2031
Figure 40: Europe Telemedicine Market Value (US$ Mn) Forecast, 2017–2031
Figure 41: Europe Telemedicine Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 42: Europe Telemedicine Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 43: Europe Telemedicine Market Value Share Analysis, by Component Type , 2021 and 2031
Figure 44: Europe Telemedicine Market Attractiveness Analysis, by Component Type, 2022–2031
Figure 45: Europe Telemedicine Market Value Share Analysis, by Specialty Type, 2021 and 2031
Figure 46: Europe Telemedicine Market Attractiveness Analysis, by Specialty Type, 2022–2031
Figure 47: Europe Telemedicine Market Value Share Analysis, by Service Type, 2021 and 2031
Figure 48: Europe Telemedicine Market Attractiveness Analysis, by Service Type, 2022–2031
Figure 49: Asia Pacific Telemedicine Market Value (US$ Mn) Forecast, 2017–2031
Figure 50: Asia Pacific Telemedicine Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 51: Asia Pacific Telemedicine Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 52: Asia Pacific Telemedicine Market Value Share Analysis, by Component Type, 2021 and 2031
Figure 53: Asia Pacific Telemedicine Market Attractiveness Analysis, by Component Type, 2022–2031
Figure 54: Asia Pacific Telemedicine Market Value Share Analysis, by Specialty Type, 2021 and 2031
Figure 55: Asia Pacific Telemedicine Market Attractiveness Analysis, by Specialty Type, 2022–2031
Figure 56: Asia Pacific Telemedicine Market Value Share Analysis, by Service Type, 2021 and 2031
Figure 57: Asia Pacific Telemedicine Market Attractiveness Analysis, by Service Type, 2022–2031
Figure 58: Latin America Telemedicine Market Value (US$ Mn) Forecast, 2017–2031
Figure 59: Latin America Telemedicine Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 60: Latin America Telemedicine Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 61: Latin America Telemedicine Market Value Share Analysis, by Component Type , 2021 and 2031
Figure 62: Latin America Telemedicine Market Attractiveness Analysis, by Component Type, 2022–2031
Figure 63: Latin America Telemedicine Market Value Share Analysis, by Specialty Type, 2021 and 2031
Figure 64: Latin America Telemedicine Market Attractiveness Analysis, by Specialty Type, 2022–2031
Figure 65: Latin America Telemedicine Market Value Share Analysis, by Service Type, 2021 and 2031
Figure 66: Latin America Telemedicine Market Attractiveness Analysis, by Service Type, 2022–2031
Figure 67: Middle East & Africa Telemedicine Market Value (US$ Mn) Forecast, 2017–2031
Figure 68: Middle East & Africa Telemedicine Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 69: Middle East & Africa Telemedicine Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 70: Middle East & Africa Telemedicine Market Value Share Analysis, by Component Type, 2021 and 2031
Figure 71: Middle East & Africa Telemedicine Market Attractiveness Analysis, by Component Type, 2022–2031
Figure 72: Middle East & Africa Telemedicine Market Value Share Analysis, by Specialty Type, 2021 and 2031
Figure 73: Middle East & Africa Telemedicine Market Attractiveness Analysis, by Specialty Type, 2022–2031
Figure 74: Middle East & Africa Telemedicine Market Value Share Analysis, by Service Type, 2021 and 2031
Figure 75: Middle East & Africa Telemedicine Market Attractiveness Analysis, by Service Type, 2022–2031
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
